Terumo Co. (OTCMKTS:TRUMY - Get Free Report) saw a significant growth in short interest in October. As of October 31st, there was short interest totalling 46,600 shares, a growth of 25.3% from the October 15th total of 37,200 shares. Based on an average trading volume of 154,300 shares, the days-to-cover ratio is presently 0.3 days.
Terumo Stock Down 1.1 %
Terumo stock traded down $0.21 during midday trading on Friday, reaching $19.49. The stock had a trading volume of 134,073 shares, compared to its average volume of 97,297. The firm's fifty day simple moving average is $19.20 and its 200-day simple moving average is $17.97. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.72 and a current ratio of 2.98. The stock has a market capitalization of $29.05 billion, a P/E ratio of 41.24 and a beta of 0.64. Terumo has a 1-year low of $14.06 and a 1-year high of $20.60.
Terumo Company Profile
(
Get Free Report)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Further Reading
Before you consider Terumo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.
While Terumo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
